home / stock / ards / ards news


ARDS News and Press, Aridis Pharmaceuticals Inc. From 12/04/23

Stock Information

Company Name: Aridis Pharmaceuticals Inc.
Stock Symbol: ARDS
Market: NASDAQ
Website: aridispharma.com

Menu

ARDS ARDS Quote ARDS Short ARDS News ARDS Articles ARDS Message Board
Get ARDS Alerts

News, Short Squeeze, Breakout and More Instantly...

ARDS - Expected US Company Earnings on Monday, December 4th, 2023

JanOne Inc. (JAN) is expected to report for Q4 2023 Staffing 360 Solutions Inc. (STAF) is expected to report $-0.31 for Q3 2023 American Virtual Cloud Technologies Inc. (AVCTQ) is expected to report for quarter end 2023-09-30 Quotient Limited (QTNTQ) is expected to report for quarter ...

ARDS - Expected US Company Earnings on Monday, November 27th, 2023

Nippon Paint Holdings Co. Ltd. (NPCPF) is expected to report for Q3 2023 SMC Corporation ADR (SMCAY) is expected to report for Q2 2024 Arcimoto Inc. (FUV) is expected to report for Q3 2023 Ever-Glory International Group Inc. (EVKG) is expected to report for quarter end 2023-09-30 ...

ARDS - Expected US Company Earnings on Monday, November 20th, 2023

AERWINS Technologies Inc. (AWIN) is expected to report for Q1 2024 Minera IRL Ltd ADR (MRLLY) is expected to report for quarter end 2023-09-30 SmileDirectClub, Inc. - Ordinary Shares - Class A (SDCCQ) is expected to report $-0.1 for Q3 2023 NextPlay Technologies Inc. (NXTP) is expecte...

ARDS - Aridis Pharmaceuticals GAAP EPS of $0.00 beats by $0.10, revenue of $0.42M misses by $1.08M

2023-11-03 16:24:25 ET More on Aridis Pharmaceuticals Seeking Alpha’s Quant Rating on Aridis Pharmaceuticals Historical earnings data for Aridis Pharmaceuticals Financial information for Aridis Pharmaceuticals For further details see: Aridis Pharma...

ARDS - Aridis Pharmaceuticals Announces Third Quarter 2023 Financial Results and Business Update

Received two grant awards from the National Institute of Allergy and Infectious Diseases, a division of the National Institutes of Health LOS GATOS, Calif., Nov. 03, 2023 (GLOBE NEWSWIRE) -- Aridis Pharmaceuticals, Inc. (OTCQB: ARDS), a biopharmaceutical company focused on the discovery a...

ARDS - Reviva Pharmaceuticals Holdings, Inc. and Aridis Pharmaceuticals, Inc. Interviews to Air on the RedChip Money Report(R) on Bloomberg TV

ORLANDO, FL / ACCESSWIRE / September 22, 2023 / RedChip Companies will air interviews with Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) and Aridis Pharmaceuticals, Inc. (OTC:ARDS) on The RedChip Money Report®, a sponsored program on Bloomberg TV, this Saturday, September 23, at 7 p.m...

ARDS - Aridis Pharmaceuticals, Inc., Genetic Technologies Limited, and American Resources Corporation Interviews to Air on the RedChip Money Report® on Bloomberg TV

ORLANDO, FL / ACCESSWIRE / September 15, 2023 / RedChip Companies will air interviews with Aridis Pharmaceuticals, Inc. (OTC:ARDS), Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE), and American Resources Corporation (Nasdaq:AREC) on The RedChip Money Report®, a sponsored program on Bloo...

ARDS - Expected US Company Earnings on Tuesday, September 12th, 2023

Farmer Brothers Company (FARM) is expected to report $-0.61 for Q4 2023 Aspen Group Inc. (ASPU) is expected to report for Q1 2023 Kaspien Holdings Inc. (KSPN) is expected to report for Q1 2024 AGC Inc ADR (ASGLY) is expected to report for Q2 2023 Shimano Inc. ADR (SMNNY) is expect...

ARDS - Expected US Company Earnings on Tuesday, September 5th, 2023

AeroVironment Inc. (AVAV) is expected to report $0.4 for Q1 2024 Jeronimo Martins - S.G.P.S., S.A. ADR (JRONY) is expected to report $0.74 for Q2 2023 TuSimple Holdings Inc. (TSP) is expected to report $-0.63 for Q2 2023 CVR Medical Corp (CRRVF) is expected to report for quarter end 2...

ARDS - Expected earnings - Aridis Pharmaceuticals Inc.

Aridis Pharmaceuticals Inc. (ARDS) is expected to report for Q2 2023

Previous 10 Next 10